Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sarah Pagliaro"'
Autor:
Jean-Claude Chomel, Christoph Desterke, Lucas de Souza, Hervé Acloque, Adlen Foudi, Annelise Bennaceur-Griscelli, Frank Griscelli, Sarah Pagliaro, Ali G. Turhan, Patricia Hugues
Publikováno v:
Experimental Hematology
Experimental Hematology, Elsevier, 2020, 85, pp.47-56. ⟨10.1016/j.exphem.2020.04.005⟩
Experimental Hematology, Elsevier, 2020, 85, pp.47-56. ⟨10.1016/j.exphem.2020.04.005⟩
International audience; Recent experimental data suggest that the heterogeneity of chronic myeloid leukemia (CML) stem cells may be the result of the development of unique molecular events generating functional consequences in terms of the resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582b0c10a07040df4b9391c133c3449d
https://pubmed.ncbi.nlm.nih.gov/32360510
https://pubmed.ncbi.nlm.nih.gov/32360510
Autor:
Christophe Desterke, Sarah Pagliaro, Julien Loisel-Duwattez, Jin Wook Hwang, Frank Griscelli, Annelise Bennaceur-Griscelli, Theodoros Latsis, Ali G. Turhan
Publikováno v:
Biochimica et biophysica acta. General subjects. 1864(4)
Background Current experimental models using either human or mouse cell lines, are not representative of the complex features of GBM. In particular, there is no model to study patient-derived iPSCs to generate a GBM model. Overexpression of c-met gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5984545ff0a6c8da70359d98a6b1db61
https://pubmed.ncbi.nlm.nih.gov/31978452
https://pubmed.ncbi.nlm.nih.gov/31978452
Autor:
Hind Rahban, Sarah Pagliaro, Emilie Cayssials, Christophe Desterke, Nathalie Sorel, Marie-Laure Bonnet, Jean-Claude Chomel, Maud Voldoire, Annelise Bennaceur-Griscelli, Ali G. Turhan
Publikováno v:
Experimental hematology. 64
The BCR-ABL oncogene, the hallmark of chronic myeloid leukemia (CML), has been shown to activate several signaling pathways in leukemic cells. The natural history of this disease has been radically modified by tyrosine kinase inhibitors (TKIs). Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d936dde19ad2dd9cb16eb8bbfa078ad
https://pubmed.ncbi.nlm.nih.gov/29733872
https://pubmed.ncbi.nlm.nih.gov/29733872
Autor:
Annelise Bennaceur-Griscelli, Jean-Claude Chomel, Sarah Pagliaro, Christophe Desterke, Ali G. Turhan, Emilie Cayssials, Maud Voldoire, Marie Laure Bonnet, Nathalie Sorel
Publikováno v:
Blood. 128:442-442
Chronic myeloid leukemia is a clonal myeloproliferative neoplasm characterized by the occurrence of the Ph1 chromosome in a primitive hematopoietic stem cell with a major amplification of myeloid compartment. Despite the major progress obtained by th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de081961bde8bc8734decc77be58acc8
https://doi.org/10.1182/blood.v128.22.442.442
https://doi.org/10.1182/blood.v128.22.442.442